Plant ID: NPO26873
Plant Latin Name: Echinochloa crus-galli
Taxonomy Genus: Echinochloa
Taxonomy Family: Poaceae
NCBI TaxonomyDB:
90397
Plant-of-the-World-Online:
n.a.
Styptic; Tonic
Jordan; India
GPBAR1; | |
PTPN1; PTPN2; CDC25B; PTPN11; | |
ALPL; PLA2G1B; TERT; HSD17B10; AKR1B10; POLB; | |
GAA; | |
NR1H4; | |
NFKB1; | |
HSF1; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
Enzyme_unclassified | PLA2G1B | Phospholipase A2 group 1B | P04054 | CHEMBL4426 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPN2 | T-cell protein-tyrosine phosphatase | P17706 | CHEMBL3807 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
Protein Phosphatase | PTPN11 | Protein-tyrosine phosphatase 2C | Q06124 | CHEMBL3864 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | HSF1 | Heat shock factor protein 1 | Q00613 | CHEMBL5869 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0035335; peptidyl-tyrosine dephosphorylation | 8.485E-07 | 5.208E-03 | CDC25B, PTPN1, PTPN11, PTPN2 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 1.688E-06 | 5.250E-03 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 1.688E-06 | 5.250E-03 | GPBAR1, NR1H4 |
BP | GO:0009987; cellular process | GO:1902202; regulation of hepatocyte growth factor receptor signaling pathway | 3.374E-06 | 7.819E-03 | PTPN1, PTPN2 |
BP | GO:0009987; cellular process | GO:0045931; positive regulation of mitotic cell cycle | 3.794E-06 | 7.819E-03 | CDC25B, HSF1, PTPN11, TERT |
BP | GO:0009987; cellular process | GO:0060338; regulation of type I interferon-mediated signaling pathway | 5.637E-06 | 7.819E-03 | PTPN1, PTPN11, PTPN2 |
BP | GO:0050896; response to stimulus | GO:0046626; regulation of insulin receptor signaling pathway | 6.832E-06 | 7.830E-03 | NR1H4, PTPN1, PTPN2 |
MF | GO:0005488; binding | GO:0097677; STAT family protein binding | 8.428E-06 | 8.739E-03 | HSF1, PTPN2 |
MF | GO:0005488; binding | GO:0030971; receptor tyrosine kinase binding | 1.025E-05 | 9.329E-03 | PTPN1, PTPN11, PTPN2 |
MF | GO:0003824; catalytic activity | GO:0004726; non-membrane spanning protein tyrosine phosphatase activity | 1.572E-05 | 1.167E-02 | PTPN11, PTPN2 |
MF | GO:0005488; binding | GO:0032052; bile acid binding | 2.020E-05 | 1.375E-02 | NR1H4, PLA2G1B |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04931 | Insulin resistance | 6.831E-05 | 5.601E-03 | PTPN1, PTPN11, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04014 | Ras signaling pathway | 5.936E-04 | 1.371E-02 | PLA2G1B, PTPN11, NFKB1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 2.256E-04 | 9.251E-03 | AKR1B10, GAA |
09160 Human Diseases | 09167 Infectious diseases | hsa05166 | HTLV-I infection | 8.607E-04 | 1.371E-02 | POLB, TERT, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 7.620E-04 | 1.371E-02 | HSF1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.162E-03 | 1.371E-02 | PTPN11, NFKB1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.610E-03 | 1.467E-02 | AKR1B10, PLA2G1B, GAA, ALPL, HSD17B10 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 1.338E-03 | 1.371E-02 | PTPN11, NFKB1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04920 | Adipocytokine signaling pathway | 1.231E-03 | 1.371E-02 | PTPN11, NFKB1 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 3.562E-03 | 2.921E-02 | PTPN11, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Multiple myeloma | C90 | TERT; |
H00-H59: Diseases of the eye and adnexa | Ocular inflammation | H16.229 | TERT; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; CDC25B; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TERT; |
C00-D49: Neoplasms | Brain cancer | C71, D33 | TERT; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TERT; |
C00-D49: Neoplasms | Breast cancer | C50 | TERT; |
C00-D49: Neoplasms | Prostate cancer | C61 | TERT; |
C00-D49: Neoplasms | Tumors | C00-D48 | TERT; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
C00-D49: Neoplasms | Colon cancer | C50 | ALPL; |
C00-D49: Neoplasms | Liver cancer | C22 | TERT; |
C00-D49: Neoplasms | Melanoma | C43 | TERT; |
Q00-Q99: Congenital malformations, deformations and chromosomal abnormalities | Genetic disease | Q00-Q99 | ALPL; |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL; |
C00-D49: Neoplasms | Ovarian cancer | C56 | TERT; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | TERT; |